Skip to content

Latest medicine updates

110 updates found

New New Updated Updated Retired Retired

NARROW IT DOWN

MEDICINE NAME

CHANGES

Date range

DOCUMENT TYPE

STATUS

Pil
tenofovir disoproxil fumarate, emtricitabine, rilpivirine hydrochloride
Updated 19-Oct-17
Updated
  • Change to section 6 - date of revision
  • Change to other sources of information section
SPC
orlistat
Updated 19-Oct-17
Updated
  • Change to section 9 - Date of first authorisation/renewal of the authorisation
  • Change to section 10 - Date of revision of the text
SPC
risperidone
Updated 19-Oct-17
Updated
  • Change to section 2 - Qualitative and quantitative composition
  • Change to section 3 - Pharmaceutical form
  • Change to section 4.2 - Posology and method of administration
  • Change to section 4.4 - Special warnings and precautions for use
  • Change to section 4.8 - Undesirable effects
  • Change to section 9 - Date of first authorisation/renewal of the authorisation
  • Change to section 10 - Date of revision of the text
SPC
risperidone
Updated 19-Oct-17
Updated
  • Change to section 2 - Qualitative and quantitative composition
  • Change to section 3 - Pharmaceutical form
  • Change to section 4.2 - Posology and method of administration
  • Change to section 4.4 - Special warnings and precautions for use
  • Change to section 4.8 - Undesirable effects
  • Change to section 9 - Date of first authorisation/renewal of the authorisation
  • Change to section 10 - Date of revision of the text
SPC
tetracosactide acetate
Updated 19-Oct-17
Updated
  • Change to section 7 - Marketing authorisation holder
  • Change to section 10 - Date of revision of the text
SPC
beclometasone dipropionate
Updated 19-Oct-17
Updated
  • Change to section 4.4 - Special warnings and precautions for use
  • Change to section 4.8 - Undesirable effects
SPC
beclometasone dipropionate
Updated 19-Oct-17
Updated
  • Change to section 4.4 - Special warnings and precautions for use
  • Change to section 4.8 - Undesirable effects
SPC
beclometasone dipropionate
Updated 19-Oct-17
Updated
  • Change to section 4.4 - Special warnings and precautions for use
  • Change to section 4.8 - Undesirable effects
SPC
beclometasone dipropionate
Updated 19-Oct-17
Updated
  • Change to section 4.4 - Special warnings and precautions for use
  • Change to section 4.8 - Undesirable effects
SPC
beclometasone dipropionate
Updated 19-Oct-17
Updated
  • Change to section 4.4 - Special warnings and precautions for use
  • Change to section 4.8 - Undesirable effects
SPC
beclometasone dipropionate
Updated 19-Oct-17
Updated
  • Change to section 4.4 - Special warnings and precautions for use
  • Change to section 4.8 - Undesirable effects
SPC
ataluren
Updated 19-Oct-17
Updated
  • Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
  • Change to section 10 - Date of revision of the text
Pil
ispaghula husk
Updated 19-Oct-17
Updated
  • Change to section 2 - what you need to know - warnings and precautions
  • Change to section 4 - possible side effects
Pil
ispaghula husk
Updated 19-Oct-17
Updated
  • Change to section 2 - what you need to know - warnings and precautions
  • Change to section 4 - possible side effects
SPC
dorzolamide hydrochloride, timolol maleate
Updated 19-Oct-17
Updated
  • Change to section 6.5 - Nature and contents of container
  • Change to section 7 - Marketing authorisation holder
Pil
ispaghula husk
Updated 19-Oct-17
Updated
  • Change to section 2 - what you need to know - warnings and precautions
  • Change to section 4 - possible side effects
SPC
metformin hydrochloride, dapagliflozin propanediol monohydrate
Updated 19-Oct-17
Updated
  • Change to section 4.2 - Posology and method of administration
  • Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
  • Change to section 4.8 - Undesirable effects
  • Change to section 5.1 - Pharmacodynamic properties
  • Change to section 5.2 - Pharmacokinetic properties
  • Change to section 6.1 - List of excipients
  • Change to section 6.5 - Nature and contents of container
  • Change to section 10 - Date of revision of the text
SPC
amitriptyline hydrochloride
Updated 19-Oct-17
Updated
  • Change to section 4.1 - Therapeutic indications
  • Change to section 4.2 - Posology and method of administration
  • Change to section 4.3 - Contraindications
  • Change to section 4.4 - Special warnings and precautions for use
  • Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
  • Change to section 4.6 - Fertility, pregnancy and lactation
  • Change to section 4.7 - Effects on ability to drive and use machines
  • Change to section 4.8 - Undesirable effects
  • Change to section 4.9 - Overdose
  • Change to section 5.1 - Pharmacodynamic properties
  • Change to section 5.2 - Pharmacokinetic properties
  • Change to section 5.3 - Preclinical safety data
  • Change to section 10 - Date of revision of the text
SPC
amitriptyline hydrochloride
Updated 19-Oct-17
Updated
  • Change to section 4.1 - Therapeutic indications
  • Change to section 4.2 - Posology and method of administration
  • Change to section 4.3 - Contraindications
  • Change to section 4.4 - Special warnings and precautions for use
  • Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
  • Change to section 4.6 - Fertility, pregnancy and lactation
  • Change to section 4.7 - Effects on ability to drive and use machines
  • Change to section 4.8 - Undesirable effects
  • Change to section 4.9 - Overdose
  • Change to section 5.1 - Pharmacodynamic properties
  • Change to section 5.2 - Pharmacokinetic properties
  • Change to section 5.3 - Preclinical safety data
  • Change to section 10 - Date of revision of the text
SPC
aciclovir
Updated 19-Oct-17
Updated
  • Change to section 7 - Marketing authorisation holder
  • Change to section 8 - Marketing authorisation number(s)
  • Change to section 10 - Date of revision of the text
SPC
nefopam hydrochloride
Updated 19-Oct-17
Updated
  • Change to section 4.4 - Special warnings and precautions for use
  • Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
  • Change to section 4.8 - Undesirable effects
  • Change to section 4.9 - Overdose
  • Change to section 10 - Date of revision of the text
Pil
solifenacin succinate
Updated 19-Oct-17
Updated
  • Change to section 6 - date of revision
  • Correction of spelling/typing errors
Pil
ispaghula husk
Updated 19-Oct-17
Updated
  • Change to section 2 - what you need to know - contraindications
  • Change to section 4 - possible side effects
Pil
ispaghula husk
Updated 19-Oct-17
Updated
  • Change to section 2 - what you need to know - contraindications
  • Change to section 4 - possible side effects
Pil
ropivacaine hydrochloride
Updated 19-Oct-17
Updated
  • Change to section 6 - date of revision
  • Change to section 6 - marketing authorisation holder
Pil
caffeine citrate
Updated 19-Oct-17
Updated
  • Change to section 6 - date of revision
SPC
TISSEEL Lyo Two-Component Fibrin Sealant
aprotinin, calcium chloride , human fibrinogen, human thrombin
Retired 19-Oct-17
Baxter Healthcare Ltd
Retired
  • Product/presentation discontinued
Pil
ataluren
Updated 19-Oct-17
Updated
  • Change to section 2 - interactions with other medicines, food or drink
  • Change to section 6 - date of revision
Pil
calcium carbonate, colecalciferol; cholecalciferol
Updated 19-Oct-17
Updated
  • Change to section 6 - date of revision
  • Change to section 6 - manufacturer
Pil
colistimethate sodium
Updated 19-Oct-17
Updated
  • Correction of spelling/typing errors
SPC
triamcinolone hexacetonide
Updated 19-Oct-17
Updated
  • Change to section 4.4 - Special warnings and precautions for use
  • Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
  • Change to section 10 - Date of revision of the text
Pil
risperidone
Updated 19-Oct-17
Updated
  • Change to section 6 - what the product contains
  • Change to section 6 - what the product looks like and pack contents
  • Change to section 2 - what you need to know - warnings and precautions
  • Change to section 5 - how to store or dispose
  • Change to section 4 - possible side effects
  • Change to section 2 - interactions with other medicines, food or drink
  • Change to section 2 - pregnancy, breast feeding and fertility
  • Change to section 6 - date of revision
  • Correction of spelling/typing errors
  • Change to section 3 - how to take/use
  • Change to section 2 - excipient warnings
Pil
nefopam hydrochloride
Updated 19-Oct-17
Updated
  • Change to section 4 - possible side effects
  • Change to section 6 - date of revision
Pil
alglucosidase alfa
Updated 19-Oct-17
Updated
  • Improved presentation of PIL
Pil
clobazam
Updated 19-Oct-17
Updated
  • Change to section 6 - date of revision
  • Change to name of medicinal product
Pil
betamethasone valerate
Updated 19-Oct-17
Updated
  • Change to section 2 - what you need to know - warnings and precautions
  • Change to section 2 - what you need to know - contraindications
  • Change to section 5 - how to store or dispose
  • Change to section 4 - possible side effects
  • Change to section 2 - pregnancy, breast feeding and fertility
  • Change to section 6 - date of revision
  • Correction of spelling/typing errors
  • Change to section 3 - how to take/use
Pil
aciclovir
Updated 19-Oct-17
Updated
  • Change to section 6 - date of revision
  • Change to section 6 - marketing authorisation holder
  • Change to section 6 - marketing authorisation number
SPC
sodium alginate, calcium carbonate, sodium bicarbonate
Updated 19-Oct-17
Updated
  • Change to section 6.5 - Nature and contents of container
SPC
simoctocog alfa
Updated 19-Oct-17
Updated
  • Change to section 4.2 - Posology and method of administration
  • Change to section 4.4 - Special warnings and precautions for use
  • Change to section 4.8 - Undesirable effects
  • Change to section 5.1 - Pharmacodynamic properties
Pil
mirabegron
Updated 19-Oct-17
Updated
  • Improved presentation of PIL
Pil
Pneumococcal polysaccharide conjugate vaccine
Updated 18-Oct-17
Updated
  • Change to section 6 - date of revision
  • Change to section 3 - how to take/use
SPC
pregabalin
Updated 18-Oct-17
Updated
  • Correction of spelling/typing errors
SPC
fluoxetine hydrochloride
Updated 18-Oct-17
Updated
  • Change to section 4.1 - Therapeutic indications
  • Change to section 4.2 - Posology and method of administration
  • Change to section 4.4 - Special warnings and precautions for use
  • Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
  • Change to section 4.6 - Fertility, pregnancy and lactation
  • Change to section 4.9 - Overdose
  • Change to section 4.8 - Undesirable effects - how to report a side effect
SPC
amoxicillin trihydrate
Updated 18-Oct-17
Updated
  • Change to section 4.1 - Therapeutic indications
  • Change to section 4.2 - Posology and method of administration
  • Change to section 4.3 - Contraindications
  • Change to section 4.4 - Special warnings and precautions for use
  • Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
  • Change to section 4.6 - Fertility, pregnancy and lactation
  • Change to section 4.7 - Effects on ability to drive and use machines
  • Change to section 4.8 - Undesirable effects
  • Change to section 4.9 - Overdose
  • Change to section 5.1 - Pharmacodynamic properties
  • Change to section 5.2 - Pharmacokinetic properties
  • Change to section 10 - Date of revision of the text
SPC
amoxicillin trihydrate
Updated 18-Oct-17
Updated
  • Change to section 4.1 - Therapeutic indications
  • Change to section 4.2 - Posology and method of administration
  • Change to section 4.3 - Contraindications
  • Change to section 4.4 - Special warnings and precautions for use
  • Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
  • Change to section 4.6 - Fertility, pregnancy and lactation
  • Change to section 4.7 - Effects on ability to drive and use machines
  • Change to section 4.8 - Undesirable effects
  • Change to section 4.9 - Overdose
  • Change to section 5.1 - Pharmacodynamic properties
  • Change to section 5.2 - Pharmacokinetic properties
  • Change to section 10 - Date of revision of the text
SPC
tetracosactide acetate
Updated 18-Oct-17
Updated
  • Change to section 7 - Marketing authorisation holder
  • Change to section 10 - Date of revision of the text
SPC
nifedipine
Updated 18-Oct-17
Updated
  • Change to section 3 - Pharmaceutical form
  • Change to section 10 - Date of revision of the text
SPC
clobetasone butyrate
Updated 18-Oct-17
Updated
  • Change to section 4.4 - Special warnings and precautions for use
  • Change to section 4.8 - Undesirable effects
  • Change to section 10 - Date of revision of the text
SPC
carbamazepine
Updated 18-Oct-17
Updated
  • Change to section 6.1 - List of excipients
  • Change to section 10 - Date of revision of the text
Pil
benzocaine, tyrothricin
Updated 18-Oct-17
Updated
  • Change to section 6 - date of revision
  • Change to section 6 - marketing authorisation holder
  • Change to section 6 - marketing authorisation number

Page 1 of 3 Next

This site uses cookies. By continuing to browse the site you are agreeing to our policy on the use of cookies. Continue